Fig. 2From: Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary interventionIndividual value plots of glycaemic parameters according to on-treatment high platelet reactivity; a HbA1c values in patients with and without HPR; b, c glycaemic variability expressed by MAGE and CV in HPR and non-HPR groups. HbA1c glycated haemoglobin, HPR high platelet reactivity, MAGE mean amplitude glycaemic excursions, CV coefficient of variabilityBack to article page